Navigation Links
Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Kearney, Nebraska
Date:11/30/2016

BOCA RATON, Fla., Nov. 30, 2016 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer of immunological biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located at 5915 1st Avenue Kearney, Nebraska. The 15,200 square foot state-of-the-art facility officially opened its doors for business on November 29th, 2016 and brings the total number of BPC's plasma collection centers to twenty-two. 

Ileana Carlisle, BPC's Chief Executive Officer said "We are pleased to become a part of Kearney's growing community and look forward to being an active member here. This facility is just one more step forward in our resolve to better serve the thousands of patients worldwide whose lives are enhanced through plasma-based therapies."   

BPC has invested approximately $1.8 million in renovations of this newly constructed facility. The Company expects to add over 40 jobs to Kearney's local economy and currently has employment opportunities available for medical personnel and phlebotomists. 

In addition to supporting the local economy through employment opportunities, the Kearney Biotest Plasma Center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material for these plasma-derived therapies which save the lives of thousands of patients but are also compensated for their donations.

About Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company researches, develops and manufactures biotherapeutic plasma protein products, with a specialization in immunology and hematology and is a leader in the collection of source plasma. Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies.

Biotest Pharmaceuticals' team of over 1000 employees is part of Biotest AG's global workforce of more than 2,300 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biotest-pharmaceuticals-corporation-announces-the-opening-of-its-newest-plasma-collection-facility-in-kearney-nebraska-300370555.html


'/>"/>
SOURCE Biotest Pharmaceuticals Corporation
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Biotest Pharmaceuticals Corporation Announces the Relocation of its Plasma Collection Facility in Youngstown, Ohio
2. Biotest Pharmaceuticals Corporation Announces the Relocation of its Plasma Collection Facility in San Antonio, Texas
3. Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Conway, Arkansas
4. Ability Pharmaceuticals Initiates Phase 2 Combination Trial with ABTL0812 as First-Line Therapy in Patients with Endometrial or Squamous Lung Cancer
5. USPTO issues patent for "Preservation by Vaporization" technology, allowing manufacture of thermostable vaccines and other fragile biopharmaceuticals
6. Eiger BioPharmaceuticals Reports Third Quarter 2016 Financial Results
7. PharmaBoardroom Releases The Netherlands Pharmaceuticals Report
8. Juniper Pharmaceuticals Appoints Mary Ann Gray, Ph.D., to Board of Directors
9. Imprimis Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters Option to Purchase Additional Shares
10. RXi Pharmaceuticals To Webcast Fourth Quarter And Year End 2015 Financial Results On Wednesday, March 30, 2016
11. Diasome Pharmaceuticals, Inc. and Lyfebulb LLC Announce Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2018)... ... July 31, 2018 , ... ... marked molecular quality controls to its expanding CE/IVD product inventory. , “We are ... expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully support and provide ...
(Date:7/26/2018)... , ... July 26, 2018 , ... ... on the impact of a biofield energy treated nutraceutical to improve anti-inflammatory and ... immune function response assessed in the preclinical research, were significantly reduced. Results are ...
(Date:7/25/2018)... ... July 25, 2018 , ... Vium, Inc. ... Digital Vivarium™ and Vium Cloud approach to accelerate preclinical drug discovery and development, ... the company announced the appointment of Jeff Caron to the newly formed role ...
(Date:7/25/2018)... ... July 25, 2018 , ... John McDonald, CEO of ... the Indiana India Business Council (IIBC), an advocacy group to strengthen economic ties ... of directors, McDonald joins an impressive roster of local and national business leaders ...
Breaking Biology Technology:
(Date:8/2/2018)... MANALAPAN, N.J. (PRWEB) , ... August 02, 2018 ... ... multi-channel sample management solutions to pharmaceutical and biotech companies, today announced that Mark ... of 100 most inspiring people in the life sciences industry. Individuals named to ...
(Date:8/1/2018)... & GILBERT, Ariz. (PRWEB) , ... July 31, ... ... A. May Father of Stevia Awards at Global Conference , Awards honor late ... May, Ph.D., president of Wisdom National Brands, presented prestigious stevia awards to a ...
(Date:7/31/2018)... ... July 31, 2018 , ... ACEA Biosciences, is a privately owned biotechnology ... just introduced the xCELLigence RTCA S16, which the ideal entry level model for exploratory ... the S16can be placed in any standard CO2 tissue culture incubator. The user ...
Breaking Biology News(10 mins):